← Back to all trials
Completed
NCT07269756
A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight Subjects
Conditions: Obesity, Overweight
Sex: All
Ages: 18 Years – 50 Years
Healthy volunteers: Yes
Phase: PHASE1
Enrollment: 40
Sponsor: Shandong Suncadia Medicine Co., Ltd.
Location: Suzhou Municipal Hospital Suzhou Jiangsu
Summary
This study is an open-label, fixed-sequence, self-controlled Phase I clinical trial conducted among obese or overweight subjects, with a planned enrollment of 40 adult subjects.
Eligibility Criteria
Inclusion Criteria:
1. Voluntarily sign the informed consent form prior to any study-related activities, understand the procedures and methods of the study, and agree to complete this study in strict accordance with the clinical study protocol;
2. Males or females aged 18-50 years (inclusive);
3. Weight ≥ 50.0 kg and \
Source: ClinicalTrials.gov (NCT07269756). StuddyBuddy aggregates publicly available trial information.
